Who makes Betamethasone dipropionate 0.064 % ointment?

Betamethasone dipropionate 0.064 % ointment is developed by LEO Pharma.

What development phase is Betamethasone dipropionate 0.064 % ointment in?

Betamethasone dipropionate 0.064 % ointment is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Betamethasone dipropionate 0.064 % ointment

LEO Pharma · Phase 1 active Small molecule

At a glance

Generic name	Betamethasone dipropionate 0.064 % ointment
Sponsor	LEO Pharma
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Betamethasone dipropionate 0.064 % ointment CI brief — competitive landscape report
Betamethasone dipropionate 0.064 % ointment updates RSS · CI watch RSS
LEO Pharma portfolio CI